RxDoctor Payments Data

Christopher Chang, NP

Nurse Practitioner · Macon, GANPI 1457090110

Payments from drug & device makers

$3,395in general payments, 2019–2025

Across 134 payments — averaging $25.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$721
  • Aurinia Pharma U.S., Inc.$468
  • Baxter Healthcare$367
  • Vifor Pharma, Inc.$302
  • Daiichi Sankyo Inc.$299
  • Mallinckrodt Hospital Products Inc.$211
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$3,34498%
  • Education$512%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,395 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$171,961
Medicare patients
390
Services billed
5,113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AuryxiaFerric Citrate21$52,879
Sevelamer Carbonate27$5,289
Calcium Acetate20$829
Bumetanide13$518
Losartan Potassium58$380
Amlodipine Besylate62$327
Hydralazine Hcl20$220
Potassium Chloride11$181
Furosemide66$167
Hydrochlorothiazide16$146
Metoprolol Succinate19$135
Esomeprazole Magnesium12$129
Carvedilol15$128
Gabapentin16$97
Nifedipine ErNifedipine14$89

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Akebia Therapeutics IncAuryxia$61$52,87921 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →